[go: up one dir, main page]

CA2238660A1 - Sequences des genes du virus de la rubeole associees a l'attenuation - Google Patents

Sequences des genes du virus de la rubeole associees a l'attenuation Download PDF

Info

Publication number
CA2238660A1
CA2238660A1 CA002238660A CA2238660A CA2238660A1 CA 2238660 A1 CA2238660 A1 CA 2238660A1 CA 002238660 A CA002238660 A CA 002238660A CA 2238660 A CA2238660 A CA 2238660A CA 2238660 A1 CA2238660 A1 CA 2238660A1
Authority
CA
Canada
Prior art keywords
cendehill
rna
rubella
virus
cdna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002238660A
Other languages
English (en)
Inventor
Janet Chantler
Karen Lund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Priority to CA002238660A priority Critical patent/CA2238660A1/fr
Priority to CA002298070A priority patent/CA2298070A1/fr
Priority to AU39237/99A priority patent/AU3923799A/en
Priority to PCT/CA1999/000479 priority patent/WO1999061637A1/fr
Publication of CA2238660A1 publication Critical patent/CA2238660A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36261—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002238660A 1998-05-22 1998-05-22 Sequences des genes du virus de la rubeole associees a l'attenuation Abandoned CA2238660A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002238660A CA2238660A1 (fr) 1998-05-22 1998-05-22 Sequences des genes du virus de la rubeole associees a l'attenuation
CA002298070A CA2298070A1 (fr) 1998-05-22 1999-05-21 Sequences genetiques du virus rubeolique associees a l'attenuation
AU39237/99A AU3923799A (en) 1998-05-22 1999-05-21 Gene sequences of rubella virus associated with attenuation
PCT/CA1999/000479 WO1999061637A1 (fr) 1998-05-22 1999-05-21 Sequences genetiques du virus rubeolique associees a l'attenuation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002238660A CA2238660A1 (fr) 1998-05-22 1998-05-22 Sequences des genes du virus de la rubeole associees a l'attenuation

Publications (1)

Publication Number Publication Date
CA2238660A1 true CA2238660A1 (fr) 1999-11-22

Family

ID=4162471

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002238660A Abandoned CA2238660A1 (fr) 1998-05-22 1998-05-22 Sequences des genes du virus de la rubeole associees a l'attenuation

Country Status (3)

Country Link
AU (1) AU3923799A (fr)
CA (1) CA2238660A1 (fr)
WO (1) WO1999061637A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936249B1 (en) 1998-04-15 2005-08-30 Genencor International, Inc. Proteins producing an altered immunogenic response and methods of making and using the same
US6838269B1 (en) 1998-04-15 2005-01-04 Genencor International, Inc. Proteins producing an altered immunogenic response and methods of making and using the same
US6835550B1 (en) 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE832758A (fr) * 1975-08-26 1976-02-26 Vaccins bivalents contre la rubeole et la cytomegalie
US5427792A (en) * 1989-08-23 1995-06-27 Biochem Immunosystems, Inc. Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
US5663065A (en) * 1991-06-28 1997-09-02 Georgia State University Research Foundation, Inc. DNA encoding infectious Rubella virus
US5439814A (en) * 1991-06-28 1995-08-08 Georgia State Research Foundation, Inc. DNA encoding infectious rubella virus
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine
WO1998020901A1 (fr) * 1996-11-12 1998-05-22 Georgia State University Research Foundation, Inc. Sequence genomique associee a la souche ra27/3 du virus de la rubeole

Also Published As

Publication number Publication date
AU3923799A (en) 1999-12-13
WO1999061637A1 (fr) 1999-12-02

Similar Documents

Publication Publication Date Title
Mundt et al. VP5 of infectious bursal disease virus is not essential for viral replication in cell culture
CA2154023C (fr) Virus recombinant infectieux a arn a brin negatif non segmente
AU2020277165B2 (en) Feline calicivirus vaccine
CN113637694B (zh) 用于疫苗中的登革热病毒嵌合式构建物的组合物及方法
EP0877086B1 (fr) Virus de la fièvre jaune (YV) recombinats vaccinaux recouvré à partir d'ADNc infectieux
JP2002325593A (ja) キメラおよび／または増殖制限されたフラビウイルス
JP2022507053A (ja) 新規ブタロタウイルス
CN111961654B (zh) 耐热表型稳定遗传、携带负标记的重组口蹄疫病毒无毒株及o/a型口蹄疫二价灭活疫苗
US5525715A (en) Method for producing RNA viruses from cDNA
CN107635579A (zh) 非天然发生的猪生殖和呼吸综合征病毒(prrsv)和使用方法
KR20150137085A (ko) 안정화된 ｆｍｄｖ 캡시드
CA2591532A1 (fr) Sequences d'acides nucleiques codant pour des proteines capables de s'associer a une pseudo-particule virale
CA2238660A1 (fr) Sequences des genes du virus de la rubeole associees a l'attenuation
US5439814A (en) DNA encoding infectious rubella virus
Yu et al. Molecular characteristics of full-length genomic segment A of three infectious bursal disease viruses in China: two attenuated strains and one virulent field strain
US5663065A (en) DNA encoding infectious Rubella virus
CN1318592C (zh) O型口蹄疫病毒dna疫苗及其制备方法
CA2342305C (fr) Mutants du pestivirus et vaccins en contenant
JP2011510672A (ja) ワクチンとして使用するための、カプシドタンパク質中に欠失を含むフラビウイルス科突然変異体
CA2298070A1 (fr) Sequences genetiques du virus rubeolique associees a l'attenuation
Ramulongo et al. Pathogenesis, biophysical stability and phenotypic variance of SAT2 foot-and-mouth disease virus
Mason Molecular characterization of the proteinase and RNA-dependent RNA polymerase of Infectious Pancreatic Necrosis Virus, a fish birnavirus
as Nontransmissible Classical Swine Fever Virus E

Legal Events

Date Code Title Description
FZDE Discontinued